These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20237039)

  • 41. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scar imaging using multislice computed tomography versus metabolic imaging by F-18 FDG positron emission tomography: a pilot study.
    Dwivedi G; Al-Shehri H; deKemp RA; Ali I; Alghamdi AA; Klein R; Scullion A; Ruddy TD; Beanlands RS; Chow BJ
    Int J Cardiol; 2013 Sep; 168(2):739-45. PubMed ID: 23102604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
    Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
    Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PET imaging in cardiology.
    Chacko GN
    Hell J Nucl Med; 2005; 8(3):140-4. PubMed ID: 16390017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease.
    Tio RA; Dabeshlim A; Siebelink HM; de Sutter J; Hillege HL; Zeebregts CJ; Dierckx RA; van Veldhuisen DJ; Zijlstra F; Slart RH
    J Nucl Med; 2009 Feb; 50(2):214-9. PubMed ID: 19164219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of myocardial viability by PET.
    Khalaf S; Chamsi-Pasha M; Al-Mallah MH
    Curr Opin Cardiol; 2019 Sep; 34(5):466-472. PubMed ID: 31393420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical use of cardiac 18 F-FDG viability PET: a retrospective study of 44 patients undergoing post-test revascularization.
    Luong TV; Ebbehoj A; Kjaerulff MLG; Nielsen R; Nielsen PH; Christiansen EH; Tolbod LP; Søndergaard E; Gormsen LC
    Int J Cardiovasc Imaging; 2022 Nov; 38(11):2447-2458. PubMed ID: 36434332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease.
    Dou KF; Yang MF; Yang YJ; Jain D; He ZX
    J Nucl Med; 2008 Dec; 49(12):1986-91. PubMed ID: 18997035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
    Chan SC; Yen TC; Ng SH; Lin CY; Wang HM; Liao CT; Fan KH; Chang JT
    J Nucl Med; 2006 Sep; 47(9):1447-54. PubMed ID: 16954552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Practical assessment of myocardial viability with a positron coincidence gamma camera using 18F-fluorodeoxyglucose in acute myocardial infarction: comparison with dedicated positron emission tomography and 201Tl single photon emission computed tomography.
    Seki R; Seki H; Toyama T; Koyama K; Endo K; Kurabayashi M
    J Cardiol; 2009 Apr; 53(2):265-71. PubMed ID: 19304132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 18F-FDG PET-Based Imaging of Myocardial Inflammation Predicts a Functional Outcome Following Transplantation of mESC-Derived Cardiac Induced Cells in a Mouse Model of Myocardial Infarction.
    Vasudevan P; Gaebel R; Doering P; Mueller P; Lemcke H; Stenzel J; Lindner T; Kurth J; Steinhoff G; Vollmar B; Krause BJ; Ince H; David R; Lang CI
    Cells; 2019 Dec; 8(12):. PubMed ID: 31835854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease.
    Cheng VY; Slomka PJ; Le Meunier L; Tamarappoo BK; Nakazato R; Dey D; Berman DS
    J Nucl Med; 2012 Apr; 53(4):575-83. PubMed ID: 22419753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positron emission tomography for assessment of viability.
    Sawada SG
    Curr Opin Cardiol; 2006 Sep; 21(5):464-8. PubMed ID: 16900009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rest-redistribution 201-Thallium single photon emission computed tomography predicts myocardial infarction and cardiac death in patients with ischemic left ventricular dysfunction.
    Perrone-Filardi P; Pace L; Dellegrottaglie S; Corrado L; Prastaro M; Cafiero M; Caiazzo G; Marzano A; Cesarano P; Gargiulo P; Paolillo S; Maglione A; Petretta A; Chiariello M
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):122-8. PubMed ID: 19377379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
    Ruers TJ; Wiering B; van der Sijp JR; Roumen RM; de Jong KP; Comans EF; Pruim J; Dekker HM; Krabbe PF; Oyen WJ
    J Nucl Med; 2009 Jul; 50(7):1036-41. PubMed ID: 19525451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial viability studies.
    Liu Y; Ghosh N; Dwivedi G; Chow BJ; deKemp RA; DaSilva J; Guo A; Garrard L; Beanlands RS; Ruddy TD
    Can J Cardiol; 2013 Sep; 29(9):1069-75. PubMed ID: 23664168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients.
    Ypenburg C; Schalij MJ; Bleeker GB; Steendijk P; Boersma E; Dibbets-Schneider P; Stokkel MP; van der Wall EE; Bax JJ
    J Nucl Med; 2006 Oct; 47(10):1565-70. PubMed ID: 17015888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction.
    van der Weerdt AP; Boellaard R; Knaapen P; Visser CA; Lammertsma AA; Visser FC
    J Nucl Med; 2004 Feb; 45(2):169-75. PubMed ID: 14960632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [F-18 fluorodeoxyglucose for diagnosis of myocardial viability: applications in clinical practice].
    Graf S; Porenta G
    Wien Med Wochenschr; 2002; 152(11-12):289-92. PubMed ID: 12138658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 18FDG SPECT to assess myocardial viability: initial experience at a hospital remote from a cyclotron.
    Thorley PJ; Beacock DJ; Trickett CA; Sivananthan UM
    Nucl Med Commun; 2000 Aug; 21(8):715-8. PubMed ID: 11039453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.